Word: abramson
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
Michael P. Abate Deborah A. Abeles Brian T. Abrams Michael S. Abramson Jaylaan Ahmad-Llewellyn Fahim Ahmed Stephanie N. Ajudua Rima Al-Mokarrab Michael E. Aldous Georgia N. Alexakis Jen J. B. Allen James A. Allison Elise B. Alschuler Mia C. R. Alvar Maneesh R. Amancharla Christopher A. Amar Jessie M. Amberg Richard H. Amberg Caitlin E. Anderson Blair M. Andresen Becky M. Antar Azunna E. Anyanwu Christina E. Anzuoni Patrick R. Aquino Ethan D. S. Ard Adam I. Arenson Eric R. Ashley David C. Atherton William F. Austin Erin L. Autry Irina Babushkina Daniel B. Baer Anna M. Baldwin...
...Clearly, then, Two Stories owes much of its musical success to Bennett's complete dedication to music. "That album was all eight classes for Al last year," says Bennett's roommate, Mike Abramson '00. "It took up so much of his time...
Those statistics could spell trouble. Dr. Jon Abramson, chairman of the pediatrics academy's immunization committee, recalls that between 1989 and 1991, when many people were becoming wary of vaccines, measles-immunization rates dropped 10% and an outbreak ensued, resulting in 55,000 cases, several thousand hospitalizations and 120 deaths. "Since we started immunizing again," Abramson says, "there have been very few outbreaks of indigenous measles...
...Steven Abramson, chairman of the FDA advisory panel, was impressed--and not at all surprised that the big drug companies were kicking up a fuss. "The cox-2 inhibitor will make it very difficult for them to compete," he says. Which could explain why Merck, Johnson & Johnson and Glaxo Wellcome are rushing to get their own versions into trial as fast as possible...
...filtration device that clears the body of arthritis-promoting substances the same way kidney dialysis cleans the blood of toxins. Within a few months the FDA will also consider a new class of anti-inflammatories called COX-2 inhibitors (a.k.a. "super aspirin") that will attack arthritis pain. Says Steven Abramson, an FDA adviser and chief of rheumatology at New York University's Hospital for Joint Diseases: "This is the most exciting time I've witnessed...